Clinical Trials Browser

Phase 4 × Gemtuzumab × Other hematologic neoplasm × Clear all

NCT01041040 2013-07-31

LAM07: Study to Analyze the Efficacy of a Risk Adapted Treatment Strategy, Including Gemtuzumab Ozogamicin (GO) During Consolidation, for Patients With Acute Myeloid Leukemia (AML)

Phase 4 Completed

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT00304447 2009-07-29

Study Evaluating the Effect of Corticosteroids on Mylotarg® Infusion-Related Adverse Events in Patients With Leukemia

Phase 4 Completed

Other hematologic neoplasm

Leukemia, Leukemia, Myeloid, Acute